Thirumalai Chemicals Share Price
Sector: Chemical Manufacturing
You have to be logged in to add this to Watchlist.
Login or Register
317.35 +1.30 (0.41%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
313.05
Today’s High
323.3
52 Week Low
189
52 Week High
362.8
317.60 +2.25 (0.71%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
313.4
Today’s High
324
52 Week Low
189.05
52 Week High
362.85
Key Metrics
- Market Cap (In Cr) 3228.81
- Beta 1.69
- Div. Yield (%) 0.32
- P/B 2.82
- TTM P/E -
- Peg Ratio -
- Sector P/E 21.56
- D/E 1.14
- Open Price 316.1
- Prev Close 316.05
Thirumalai Chemicals Analysis
Price Analysis
-
1 Week-0.91%
-
3 Months-7.47%
-
6 Month19.52%
-
YTD43.63%
-
1 Year64.76%
Risk Meter
- 42% Low risk
- 42% Moderate risk
- 42% Balanced Risk
- 42% High risk
- 42% Extreme risk
Thirumalai Chemicals News
Thirumalai Chemicals Q3 FY24 Results: Loss at ₹22.97Cr, Revenue Decreased by 3.21% YoY
1 min read . 08 Feb 2024Thirumalai Chemicals Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 2083.13
- Selling/ General/ Admin Expenses Total
- 79.82
- Depreciation/ Amortization
- 41.71
- Other Operating Expenses Total
- 288.27
- Total Operating Expense
- 2073.82
- Operating Income
- 9.31
- Net Income Before Taxes
- -34.55
- Net Income
- -38.79
- Diluted Normalized EPS
- -3.79
- Period
- 2024
- Total Assets
- 3320.27
- Total Liabilities
- 2174.06
- Total Equity
- 1146.21
- Tangible Book Valueper Share Common Eq
- 111.89
- Period
- 2024
- Cashfrom Operating Activities
- 237.05
- Cashfrom Investing Activities
- -822.78
- Cashfrom Financing Activities
- 642.68
- Net Changein Cash
- 64.15
- Period
- 2023
- Total Revenue
- 2132.24
- Selling/ General/ Admin Expenses Total
- 259.44
- Depreciation/ Amortization
- 55.68
- Other Operating Expenses Total
- 11.62
- Total Operating Expense
- 2001.21
- Operating Income
- 131.03
- Net Income Before Taxes
- 129.41
- Net Income
- 89.83
- Diluted Normalized EPS
- 8.77
- Period
- 2023
- Total Assets
- 2360.24
- Total Liabilities
- 1168.32
- Total Equity
- 1191.92
- Tangible Book Valueper Share Common Eq
- 116.35
- Period
- 2023
- Cashfrom Operating Activities
- 54.13
- Cashfrom Investing Activities
- -358.96
- Cashfrom Financing Activities
- 205.8
- Net Changein Cash
- -75.31
- Period
- 2022
- Total Revenue
- 1998.19
- Selling/ General/ Admin Expenses Total
- 246.54
- Depreciation/ Amortization
- 56.63
- Other Operating Expenses Total
- 9.24
- Total Operating Expense
- 1612.31
- Operating Income
- 385.88
- Net Income Before Taxes
- 375.37
- Net Income
- 281.23
- Diluted Normalized EPS
- 27.47
- Period
- 2022
- Total Assets
- 1861.59
- Total Liabilities
- 776.58
- Total Equity
- 1085.01
- Tangible Book Valueper Share Common Eq
- 105.92
- Period
- 2022
- Cashfrom Operating Activities
- 402.34
- Cashfrom Investing Activities
- -138.86
- Cashfrom Financing Activities
- -69.98
- Net Changein Cash
- 198.3
- Period
- 2021
- Total Revenue
- 1085.74
- Selling/ General/ Admin Expenses Total
- 155.74
- Depreciation/ Amortization
- 49.52
- Other Operating Expenses Total
- 6.49
- Total Operating Expense
- 913.86
- Operating Income
- 171.88
- Net Income Before Taxes
- 157.13
- Net Income
- 117.69
- Diluted Normalized EPS
- 11.49
- Period
- 2021
- Total Assets
- 1343.22
- Total Liabilities
- 540.33
- Total Equity
- 802.89
- Tangible Book Valueper Share Common Eq
- 78.37
- Period
- 2021
- Cashfrom Operating Activities
- 220.77
- Cashfrom Investing Activities
- -157.33
- Cashfrom Financing Activities
- -37.97
- Net Changein Cash
- 24.25
- Period
- 2020
- Total Revenue
- 1084.79
- Selling/ General/ Admin Expenses Total
- 138.73
- Depreciation/ Amortization
- 44.07
- Other Operating Expenses Total
- 7.34
- Total Operating Expense
- 1046.55
- Operating Income
- 38.24
- Net Income Before Taxes
- 38.16
- Net Income
- 23.17
- Diluted Normalized EPS
- 2.38
- Period
- 2020
- Total Assets
- 1200.02
- Total Liabilities
- 561.88
- Total Equity
- 638.14
- Tangible Book Valueper Share Common Eq
- 62.27
- Period
- 2020
- Cashfrom Operating Activities
- 139.67
- Cashfrom Investing Activities
- -37.81
- Cashfrom Financing Activities
- 45.69
- Net Changein Cash
- 149.72
- Period
- 2019
- Total Revenue
- 1261.04
- Selling/ General/ Admin Expenses Total
- 138.01
- Depreciation/ Amortization
- 36.35
- Other Operating Expenses Total
- 6.27
- Total Operating Expense
- 1089.99
- Operating Income
- 171.05
- Net Income Before Taxes
- 168.86
- Net Income
- 113.57
- Diluted Normalized EPS
- 11.09
- Period
- 2019
- Total Assets
- 1140.84
- Total Liabilities
- 472.99
- Total Equity
- 667.85
- Tangible Book Valueper Share Common Eq
- 65.15
- Period
- 2019
- Cashfrom Operating Activities
- 233.93
- Cashfrom Investing Activities
- -220.39
- Cashfrom Financing Activities
- 15.78
- Net Changein Cash
- 29.1
- Period
- 2018
- Total Revenue
- 1337.56
- Selling/ General/ Admin Expenses Total
- 168.46
- Depreciation/ Amortization
- 30.55
- Other Operating Expenses Total
- 8.63
- Total Operating Expense
- 1071.7
- Operating Income
- 265.86
- Net Income Before Taxes
- 253
- Net Income
- 170.44
- Diluted Normalized EPS
- 16.64
- Period
- 2018
- Total Assets
- 825.16
- Total Liabilities
- 252.2
- Total Equity
- 572.96
- Tangible Book Valueper Share Common Eq
- 55.91
- Period
- 2018
- Cashfrom Operating Activities
- 80.82
- Cashfrom Investing Activities
- -53.97
- Cashfrom Financing Activities
- -16.44
- Net Changein Cash
- 10.42
- Period
- 2024-09-30
- Total Revenue
- 525.14
- Selling/ General/ Admin Expenses Total
- 22.06
- Depreciation/ Amortization
- 13.39
- Other Operating Expenses Total
- 82.15
- Total Operating Expense
- 515.03
- Operating Income
- 10.11
- Net Income Before Taxes
- 9.16
- Net Income
- 4.89
- Diluted Normalized EPS
- 0.48
- Period
- 2024-09-30
- Total Assets
- 3468.57
- Total Liabilities
- 2258.94
- Total Equity
- 1209.63
- Tangible Book Valueper Share Common Eq
- 118.08
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -47.07
- Cashfrom Investing Activities
- -192.03
- Cashfrom Financing Activities
- 66.11
- Net Changein Cash
- -168.27
- Period
- 2024-06-30
- Total Revenue
- 554.66
- Selling/ General/ Admin Expenses Total
- 19.93
- Depreciation/ Amortization
- 13.82
- Other Operating Expenses Total
- 70.33
- Total Operating Expense
- 537.79
- Operating Income
- 16.87
- Net Income Before Taxes
- 10.91
- Net Income
- 5.09
- Diluted Normalized EPS
- 0.5
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 526.52
- Selling/ General/ Admin Expenses Total
- 19.72
- Depreciation/ Amortization
- 16.53
- Other Operating Expenses Total
- 75.35
- Total Operating Expense
- 539.25
- Operating Income
- -12.73
- Net Income Before Taxes
- -18.69
- Net Income
- -20.47
- Diluted Normalized EPS
- -2
- Period
- 2024-03-31
- Total Assets
- 3320.27
- Total Liabilities
- 2174.06
- Total Equity
- 1146.21
- Tangible Book Valueper Share Common Eq
- 111.89
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 237.05
- Cashfrom Investing Activities
- -822.78
- Cashfrom Financing Activities
- 642.68
- Net Changein Cash
- 64.15
- Period
- 2023-12-31
- Total Revenue
- 491.9
- Selling/ General/ Admin Expenses Total
- 17.63
- Depreciation/ Amortization
- 15.39
- Other Operating Expenses Total
- 70.26
- Total Operating Expense
- 513.28
- Operating Income
- -21.38
- Net Income Before Taxes
- -28.63
- Net Income
- -22.97
- Diluted Normalized EPS
- -2.24
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 542.05
- Selling/ General/ Admin Expenses Total
- 21.94
- Depreciation/ Amortization
- 15.78
- Other Operating Expenses Total
- 66.75
- Total Operating Expense
- 542.4
- Operating Income
- -0.35
- Net Income Before Taxes
- -4.08
- Net Income
- -6
- Diluted Normalized EPS
- -0.59
- Period
- 2023-09-30
- Total Assets
- 2875.49
- Total Liabilities
- 1662.62
- Total Equity
- 1212.87
- Tangible Book Valueper Share Common Eq
- 118.44
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 31.15
- Cashfrom Investing Activities
- -370.94
- Cashfrom Financing Activities
- 384.39
- Net Changein Cash
- 50.64
- Period
- 2023-06-30
- Total Revenue
- 522.66
- Selling/ General/ Admin Expenses Total
- 20.53
- Depreciation/ Amortization
- 15.5
- Other Operating Expenses Total
- 75.91
- Total Operating Expense
- 500.38
- Operating Income
- 22.28
- Net Income Before Taxes
- 16.85
- Net Income
- 10.65
- Diluted Normalized EPS
- 1.04
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 430.93
- Selling/ General/ Admin Expenses Total
- 20.3
- Depreciation/ Amortization
- 15.97
- Other Operating Expenses Total
- 91.71
- Total Operating Expense
- 447.61
- Operating Income
- -16.68
- Net Income Before Taxes
- -12.8
- Net Income
- -12.84
- Diluted Normalized EPS
- -1.25
- Period
- 2023-03-31
- Total Assets
- 2360.24
- Total Liabilities
- 1168.32
- Total Equity
- 1191.92
- Tangible Book Valueper Share Common Eq
- 116.35
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 54.13
- Cashfrom Investing Activities
- -358.96
- Cashfrom Financing Activities
- 205.8
- Net Changein Cash
- -75.31
- Period
- 2022-12-31
- Total Revenue
- 508.21
- Selling/ General/ Admin Expenses Total
- 18.13
- Depreciation/ Amortization
- 13.81
- Other Operating Expenses Total
- 74.05
- Total Operating Expense
- 493.19
- Operating Income
- 15.02
- Net Income Before Taxes
- 14.16
- Net Income
- 8.3
- Diluted Normalized EPS
- 0.81
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Thirumalai Chemicals Technical
Moving Average
SMA
- 5 Day316.61
- 10 Day321.99
- 20 Day312.55
- 50 Day319.22
- 100 Day321.05
- 300 Day288.22
Thirumalai Chemicals Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- India Glycols
- 1129.45
- 19.15
- 1.72
- 1545
- 685
- 3496.95
- Savita Oil Technologies
- 479.55
- 2.15
- 0.45
- 655
- 315
- 3313.71
- Thirumalai Chemicals
- 317.35
- 1.3
- 0.41
- 362.8
- 189
- 3250.56
- Fischer Medical Ventures
- 631.8
- -1.05
- -0.17
- 792.65
- 89.84
- 33738.12
- Kiri Industries
- 574.65
- -15.6
- -2.64
- 603
- 269
- 2978.65
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- India Glycols
- 20.82
- 1.73
- 10.97
- 2.6
- Savita Oil Technologies
- 17.1
- 2.08
- 17.05
- 7.05
- Thirumalai Chemicals
- -
- 2.89
- 10.23
- 5.64
- Fischer Medical Ventures
- 371.61
- 40.44
- 4.18
- 7.82
- Kiri Industries
- 20.66
- 0.98
- 10.87
- 22.22
Thirumalai Chemicals Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-Oct-24
- Quarterly Results
- 24-Jul-24
- Quarterly Results
- 15-May-24
- Audited Results & Final Dividend
- 06-Feb-24
- Quarterly Results
- 24-Jan-24
- Quarterly Results
- 03-Nov-23
- Quarterly Results
- 22-Jul-23
- Quarterly Results
- 17-May-23
- Audited Results & Dividend
- 25-Jan-23
- Quarterly Results
- 26-Oct-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 24-Jul-24
- 25-Jun-24
- AGM
- 22-Jul-23
- 28-Jun-23
- AGM
- 27-Jul-22
- 30-Jun-22
- AGM
- 21-Jul-21
- 21-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 15-May-24
- -
- 16-Jul-24
- 1
- 17-May-23
- -
- 14-Jul-23
- 1.5
- 26-May-22
- -
- 19-Jul-22
- 2.5
- 26-May-21
- -
- 13-Jul-21
- 2.2